The costs for Ozempic and Wegovy injections are being reduced in a limited-time four-month deal, Novo Nordisk announced on Monday.

The introductory price applies only to the lowest strength injections—0.25 mg and 0.5 mg—of Wegovy or Ozempic, lowering the out-of-pocket cost to $199 per month for new self-pay patients between now and March 31, 2026.

Why It Matters

These medications work by lowering blood-sugar levels and are typically used to treat those with type 2 diabetes, but more recently have also been used for weight loss and obesity.

They have become increasingly popular because of their notable impact on a person's ability to drop weight . Ozempic is Food and Drug Administration (FDA) approved for type 2 diabetes, reducing cardiovascular risk and chronic kidney disease,

See Full Page